Fortis Life Sciences Will Exhibit at SITC 2024

Waltham, MA and Montgomery, TX - The Fortis Life Sciences® team is excited to welcome the immuno-oncology scientific community to our backyard when the Society for Immunotherapy of Cancer (SITC) annual meeting arrives in Houston, TX from November 8-9, 2024.

The Fortis Life Sciences team will be presenting two posters on Friday, November 8, 2024 in the George R. Brown Convention Center, Level 1 – Exhibit Halls AB.

• Development and application of an end-to-end staining and analysis pipeline to identify immune cell infiltrates in oral cancer samples using a targeted multiplex immunohistochemistry antibody panel.

  Authors: Danielle M. Fails, MS, RLAT¹, Trevor McKee, PhD^2,3, Michael Spencer, PhD¹ and Alyssa Hernandez, AS¹, (1Fortis Life Sciences, Montgomery, TX, United States, 2Pathomics.io, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada)

• Utilizing the AbNano™ VHH Naïve Library for identifying and characterizing VHH binders to key immuno-oncology targets

  Authors: Amber D. Miller, PhD, Qiang Chen, Jessica Tracy, PhD, Kathy Henze, Fiona H.Y. Yuen, Liz Wilson, Kallie Kilchrist, Nathan Lee, Monique N. Navarro, Andrea Ceron, Michael Spencer, PhD and Sam Sugerman, PhD (Fortis Life Sciences, Montgomery, TX and San Diego, CA)

Additionally, Fortis Life Sciences will be located at Booth 930 in the George R. Brown Convention Center on Friday, November 8 and Saturday, November 9, 2024. Fortis will be highlighting its end-to-end spatial biology workflows and its 50+ years of expertise in antibody discovery and engineering, as well as an extensive catalog of RUO antibodies for immuno-oncology research. Furthermore, the Fortis team is excited to share new data about the AbNano™ VHH naïve library, a fully natural phage display library that has shown great promise in identifying binders to key immuno-oncology targets such as PD-L1.

Fortis is committed to partnering with diagnostic and life sciences companies to solve their most complex development problems. By exhibiting at the SITC annual meeting, Fortis reinforces the importance of immunotherapy research to global health, and strengthens its partnership with the scientific community.

About Fortis Life Sciences, LLC

Fortis partners with diagnostics and life sciences companies to custom-design, validate, and manufacture proprietary solutions to solve their most difficult development problems. Fortis’ tailored approach and end-to-end capabilities accelerate the work of its customers as they bring the next generation of medicines and diagnostics to market. Fortis serves a global customer base with offices throughout North America, including three ISO 13485 registered manufacturing facilities. To learn more about Fortis, please visit www.fortislife.com.